MDxHealth
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
16 okt 2007 - 14:59
Statutaire naam
MDxHealth
Titel
OncoMethylome Sciences Successfully Completes Private Share Offering Raising €10.6 million
Bericht
Liege (Belgium) – October 16, 2007, 14:45 CET – OncoMethylome Sciences SA (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) announces that it has raised €10.6 million through a private placement to institutional and qualified investors.
The accelerated bookbuild offering announced this morning has allowed OncoMethylome to place 1,063,351 new shares with institutional and qualified investors at a price of €10.00 per share, raising €10.6 million.
The share offering was more than two times oversubscribed due to interest from a large number of high-quality European institutional investors.
Subject to certain conditions that are standard for this type of transaction, the shares will be issued and paid for on October 19, 2007. The Company will apply for admission of the shares on Eurolist by Euronext Brussels and Euronext Amsterdam.
Commenting on today’s offering, Herman Spolders, CEO of OncoMethylome, said: “I am very pleased that we have secured this additional funding which reinforces our financial position and will support our product development and clinical trials. The funds were raised from a broad range of institutional investors thus further strengthening our shareholder base and share liquidity.”
The shares were placed by Piper Jaffray Ltd., Kempen & Co and ING Belgium.
Gerelateerde downloads
Datum laatste update: 28 juli 2024